BSECorp Action24 Aug 2026 · 24 Aug 2026, 06:01 pm
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24, 2026.
Advanced Enzyme Technologies Ltd · 540025
✦ AI SummaryBuyback
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the equity shares bought back on August 24, 2026. The company has bought 40,876 equity shares through Emkay Global Financial Services Limited at an average price of ₹302.7754.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Attachments (1)
📄pdf
Download →
6d1d415c-5253-4dae-ae21-d9884469def3.pdf
View document text
August 24, 2026
The Listing Department The Listing Department
BSE Limited National Stock Exchange of India Limited
1st Floor, New Trading Ring, Rotunda Building, P.J. Exchange Plaza, Plot No. C/1, G Block
Towers, Bandra-Kurla Complex,
Dalal Street, Fort, Mumbai — 400 001 Bandra (East), Mumbai- 400 051
Scrip Code: 540025 Symbol: ADVENZYMES
Dear Sir/ Madam,
Sub: Buyback by Advanced Enzyme Technologies Limited (“Company”) of its fully paid-up Equity Shares
of face value of ₹ 2/- each (Rupees Two only) (“Equity Share(s)”) from the open market through stock
exchanges mechanism pursuant to the provisions of the SEBI (Buy-Back of Securities) Regulations, 2018 as
amended (“Buyback Regulations”).
With reference to the captioned matter, the Company hereby submits the daily report pursuant to Regulation
18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24, 2026:
Name of the Broker Number of Equity Shares bought Total Equity Average Price
back on August 24, 2026 Shares bought of acquisition
BSE NSE MSEI back (A) (₹)*
Emkay Global Financial NIL 40,876 N.A. 40,876 302.7754
Services Limited
Cumulative Equity Shares bought as on Yesterday (B) (i.e. till August 21, 2026) 5,18,668
Less: Quantity Closed Out Today (C) 0
Quantity Closed Out as on Yesterday (D) 0
Total Quantity closed out (C+D=E) 0
Total Equity Shares bought back as on August 24, 2026 (A)+(B) - (E) 5,59,544
*Excludes Transaction Cost;
N.A. – Not applicable
The details will also be made available on the website of the Company at www.advancedenzymes.com and
on the websites of the stock exchanges where the shares of the Company are listed at www.bseindia.com and
www.nseindia.com.
Capitalized terms used and not defined herein shall have the meaning ascribed to them in the Public
Announcement.
This is for your information and records.
Yours faithfully
For Advanced Enzyme Technologies Limited
Sanjay Basantani
Company Secretary and Head-Legal
Membership No.: A19637